Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease in The New England Journal of Medicine Life Science Investing
RenovoRx Named to Fast Company's Annual List of the World's Most Innovative Companies of 2026 Life Science Investing
Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides Life Science Investing
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society 2026 International Conference Life Science Investing
Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines Life Science Investing
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy Life Science Investing
Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 Associated Plexiform Neurofibromas Causing Significant Morbidity Life Science Investing
Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging Life Science Investing
Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions Life Science Investing
